{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:29:11Z","timestamp":1792798151862,"version":"4.5.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10787-025-01704-2","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T14:24:18Z","timestamp":1741616658000},"page":"1817-1831","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies"],"prefix":"10.1007","volume":"33","author":[{"given":"Mini","family":"Dahiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monu","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9506-6197","authenticated-orcid":false,"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"issue":"17","key":"1704_CR1","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1523\/JNEUROSCI.19-17-07300.1999","volume":"19","author":"MA Abbott","year":"1999","unstructured":"Abbott MA, Wells DG, Fallon JR (1999) The insulin receptor tyrosine kinase substrate p58\/53 and the insulin receptor are components of CNS synapses. J Neurosci 19(17):7300\u20137308. https:\/\/doi.org\/10.1523\/JNEUROSCI.19-17-07300.1999","journal-title":"J Neurosci"},{"issue":"3","key":"1704_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00213-010-2076-4","volume":"214","author":"PM Abdul Muneer","year":"2011","unstructured":"Abdul Muneer PM, Alikunju S, Szlachetka AM, Haorah J (2011) Inhibitory effects of alcohol on glucose transport across the blood-brain barrier leads to neurodegeneration: preventive role of acetyl-L: -carnitine. Psychopharmacology 214(3):707\u2013718. https:\/\/doi.org\/10.1007\/s00213-010-2076-4","journal-title":"Psychopharmacology"},{"key":"1704_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2020.104707","volume":"135","author":"A Akhtar","year":"2020","unstructured":"Akhtar A, Sah SP (2020) Insulin signalling pathway and related molecules: Role in neurodegeneration and Alzheimer\u2019s disease. Neurochem Int 135:104707. https:\/\/doi.org\/10.1016\/j.neuint.2020.104707","journal-title":"Neurochem Int"},{"issue":"4","key":"1704_CR4","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.3390\/ijms24043754","volume":"24","author":"J Andrade-Guerrero","year":"2023","unstructured":"Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodr\u00edguez I, Cadena-Su\u00e1rez AR, S\u00e1nchez-Garibay C, Pozo-Molina G, M\u00e9ndez-Catal\u00e1 CF, Cardenas-Aguayo MD, Diaz-Cintra S, Pacheco-Herrero M, Luna-Mu\u00f1oz J, Soto-Rojas LO (2023a) Alzheimer\u2019s disease: an updated overview of its genetics. Int J Mol Sci 24(4):3754. https:\/\/doi.org\/10.3390\/ijms24043754","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1704_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, Craft S, Gandy S, Buettner C, Stoeckel LE, Holtzman DM, Nathan DM (2018) Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol 14(3):168\u2013181. https:\/\/doi.org\/10.1038\/nrneurol.2017.185","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"1704_CR6","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1111\/j.1582-4934.2009.00815.x","volume":"14","author":"G Aviello","year":"2010","unstructured":"Aviello G, Rowland I, Gill CI, Acquaviva AM, Capasso F, McCann M, Capasso R, Izzo AA, Borrelli F (2010) Anti-proliferative effect of rhein, an anthraquinone isolated from Cassia species, on Caco-2 human adenocarcinoma cells. J Cell Mol Med 14(7):2006\u20132014. https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00815.x","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1704_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","volume":"136","author":"WA Banks","year":"2012","unstructured":"Banks WA, Owen JB, Erickson MA (2012) Insulin in the brain: there and back again. Pharmacol Ther 136(1):82\u201393. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.07.006","journal-title":"Pharmacol Ther"},{"issue":"1","key":"1704_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/path.5056","volume":"245","author":"AF Batista","year":"2018","unstructured":"Batista AF, Forny-Germano L, Clarke JR, Silva LE, Brito-Moreira J, Boehnke SE, Winterborn A, Coe BC, Lablans A, Vital JF, Marques SA, Martinez AM, Gralle M, Holscher C, Klein WL, Houzel JC, Ferreira ST, Munoz DP, De Felice FG (2018) The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer\u2019s disease. J Pathol 245(1):85\u2013100. https:\/\/doi.org\/10.1002\/path.5056","journal-title":"J Pathol"},{"issue":"9","key":"1704_CR9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnins.2015.00204","volume":"16","author":"G Bedse","year":"2015","unstructured":"Bedse G, Di Domenico F, Serviddio G, Cassano T (2015) Aberrant insulin signalling in Alzheimer\u2019s disease: current knowledge. Front Neurosci 16(9):204. https:\/\/doi.org\/10.3389\/fnins.2015.00204","journal-title":"Front Neurosci"},{"issue":"2","key":"1704_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000106378","volume":"86","author":"C Benedict","year":"2007","unstructured":"Benedict C, Hallschmid M, Schultes B, Born J, Kern W (2007) Intranasal insulin to improve memory function in humans. Neuroendocrinology 86(2):136\u2013142. https:\/\/doi.org\/10.1159\/000106378","journal-title":"Neuroendocrinology"},{"issue":"4","key":"1704_CR11","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1210\/jc.2007-2606","volume":"93","author":"C Benedict","year":"2008","unstructured":"Benedict C, Kern W, Schultes B, Born J, Hallschmid M (2008) Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J Clin Endocrinol Metab 93(4):1339\u20131344. https:\/\/doi.org\/10.1210\/jc.2007-2606","journal-title":"J Clin Endocrinol Metab"},{"key":"1704_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.560375","volume":"11","author":"J Berlanga-Acosta","year":"2020","unstructured":"Berlanga-Acosta J, Guill\u00e9n-Nieto G, Rodr\u00edguez-Rodr\u00edguez N, Bringas-Vega ML, Garc\u00eda-Del-Barco-Herrera D, Berlanga-Saez JO, Garc\u00eda-Ojalvo A, Vald\u00e9s-Sosa MJ, Vald\u00e9s-Sosa PA (2020) Insulin resistance at the crossroad of Alzheimer disease pathology: a review. Front Endocrinol (Lausanne) 11:560375. https:\/\/doi.org\/10.3389\/fendo.2020.560375","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1704_CR13","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256","volume":"122","author":"TR Bomfim","year":"2012","unstructured":"Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel JC, Decker H, Silverman MA, Kazi H, Melo HM, McClean PL, Holscher C, Arnold SE, Talbot K, Klein WL, Munoz DP, Ferreira ST, De Felice FG (2012) An anti-diabetes agent protects the mouse brain from defective insulin signalling caused by Alzheimer\u2019s disease- associated A\u03b2 oligomers. J Clin Invest 122(4):1339\u20131353. https:\/\/doi.org\/10.1172\/JCI57256","journal-title":"J Clin Invest"},{"issue":"7343","key":"1704_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nature09788","volume":"472","author":"MA Burguillos","year":"2011","unstructured":"Burguillos MA, Deierborg T, Kavanagh E, Persson A, Hajji N, Garcia-Quintanilla A, Cano J, Brundin P, Englund E, Venero JL, Joseph B (2011) Caspase signalling controls microglia activation and neurotoxicity. Nature 472(7343):319\u2013324. https:\/\/doi.org\/10.1038\/nature09788","journal-title":"Nature"},{"issue":"5","key":"1704_CR16","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/cells10051236","volume":"10","author":"J Burillo","year":"2021","unstructured":"Burillo J, Marqu\u00e9s P, Jim\u00e9nez B, Gonz\u00e1lez-Blanco C, Benito M, Guill\u00e9n C (2021) Insulin resistance and diabetes mellitus in Alzheimer\u2019s disease. Cells 10(5):1236. https:\/\/doi.org\/10.3390\/cells10051236","journal-title":"Cells"},{"key":"1704_CR17","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"10","author":"MA Busche","year":"2020","unstructured":"Busche MA, Hyman BT (2020) Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease. Nat Neurosci 10:1183\u20131193. https:\/\/doi.org\/10.1038\/s41593-020-0687-6","journal-title":"Nat Neurosci"},{"key":"1704_CR18","first-page":"1693","volume":"1842","author":"DA Butterfield","year":"2014","unstructured":"Butterfield DA, di Domenico F, Barone E (2014) Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain. Biochem Biophys Acta 1842:1693\u20131706","journal-title":"Biochem Biophys Acta"},{"issue":"2","key":"1704_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nm1166","volume":"11","author":"D Cai","year":"2005","unstructured":"Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11(2):183\u2013190. https:\/\/doi.org\/10.1038\/nm1166","journal-title":"Nat Med"},{"key":"1704_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ejphar.2018.03.024","volume":"827","author":"Y Cao","year":"2018","unstructured":"Cao Y, H\u00f6lscher C, Hu MM, Wang T, Zhao F, Bai Y, Zhang J, Wu MN, Qi JS (2018) DA5-CH, a novel GLP-1\/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP\/PS1 mouse model of Alzheimer\u2019s disease. Eur J Pharmacol 827:215\u2013226. https:\/\/doi.org\/10.1016\/j.ejphar.2018.03.024","journal-title":"Eur J Pharmacol"},{"issue":"Pt B","key":"1704_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.neuropharm.2017.11.037","volume":"136","author":"CD Chapman","year":"2018","unstructured":"Chapman CD, Schi\u00f6th HB, Grillo CA, Benedict C (2018) Intranasal insulin in Alzheimer\u2019s disease: Food for thought. Neuropharmacology 136(Pt B):196\u2013201. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.11.037","journal-title":"Neuropharmacology"},{"key":"1704_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","volume":"108","author":"Z Chen","year":"2013","unstructured":"Chen Z, Zhong C (2013) Decoding Alzheimer\u2019s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol 108:21\u201343. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.06.004","journal-title":"Prog Neurobiol"},{"issue":"4","key":"1704_CR23","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1124\/pr.112.007120","volume":"65","author":"Y Cheng","year":"2013","unstructured":"Cheng Y, Ren X, Hait WN, Yang JM (2013) Therapeutic targeting of autophagy in disease: biology and pharmacology. Pharmacol Rev 65(4):1162\u20131197. https:\/\/doi.org\/10.1124\/pr.112.007120","journal-title":"Pharmacol Rev"},{"issue":"2","key":"1704_CR24","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.yexcr.2016.08.013","volume":"347","author":"MC Chiang","year":"2016","unstructured":"Chiang MC, Cheng YC, Chen SJ, Yen CH, Huang RN (2016) Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction. Exp Cell Res 347(2):322\u2013331. https:\/\/doi.org\/10.1016\/j.yexcr.2016.08.013","journal-title":"Exp Cell Res"},{"key":"1704_CR25","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.bbadis.2015.01.006","volume":"5","author":"MM Chung","year":"2015","unstructured":"Chung MM, Chen YL, Pei D, Cheng YC, Sun B, Nicol CJ, Yen CH, Chen HM, Liang YJ (2015) The neuroprotective role of metformin in advanced glycation end product treated human neural stem cells is AMPK-dependent. Biochim Biophys Acta 5:720\u2013731. https:\/\/doi.org\/10.1016\/j.bbadis.2015.01.006","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"1704_CR26","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.2337\/db06-0485","volume":"55","author":"BJ Clodfelder-Miller","year":"2006","unstructured":"Clodfelder-Miller BJ, Zmijewska AA, Johnson GV, Jope RS (2006) Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Diabetes 55(12):3320\u20133325. https:\/\/doi.org\/10.2337\/db06-0485","journal-title":"Diabetes"},{"issue":"1\u20132","key":"1704_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.exger.2006.08.009","volume":"42","author":"GM Cole","year":"2007","unstructured":"Cole GM, Frautschy SA (2007) The role of insulin and neurotrophic factor signalling in brain aging and Alzheimer\u2019s Disease. Exp Gerontol 42(1\u20132):10\u201321. https:\/\/doi.org\/10.1016\/j.exger.2006.08.009","journal-title":"Exp Gerontol"},{"issue":"10","key":"1704_CR28","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","volume":"55","author":"KD Copps","year":"2012","unstructured":"Copps KD, White MF (2012) Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 55(10):2565\u20132582. https:\/\/doi.org\/10.1007\/s00125-012-2644-8","journal-title":"Diabetologia"},{"issue":"6","key":"1704_CR30","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/s0306-4530(02)00087-2","volume":"28","author":"S Craft","year":"2003","unstructured":"Craft S, Asthana S, Cook DG, Baker LD, Cherrier M, Purganan K, Wait C, Petrova A, Latendresse S, Watson GS, Newcomer JW, Schellenberg GD, Krohn AJ (2003) Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer\u2019s disease: interactions with apolipoprotein E genotype. Psychoneuroendocrinology 28(6):809\u2013822. https:\/\/doi.org\/10.1016\/s0306-4530(02)00087-2","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"1704_CR31","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3233\/JAD-161256","volume":"57","author":"S Craft","year":"2017","unstructured":"Craft S, Claxton A, Baker LD, Hanson AJ, Cholerton B, Trittschuh EH, Dahl D, Caulder E, Neth B, Montine TJ, Jung Y, Maldjian J, Whitlow C, Friedman S (2017) Effects of regular and long-acting insulin on cognition and Alzheimer\u2019s disease biomarkers: a pilot clinical trial. J Alzheimers Dis 57(4):1325\u20131334. https:\/\/doi.org\/10.3233\/JAD-161256","journal-title":"J Alzheimers Dis"},{"key":"1704_CR32","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/S0168-8227(11)70014-6","volume":"93","author":"G Dimitriadis","year":"2011","unstructured":"Dimitriadis G, Mitrou P, Lambadiari V, Maratou E, Raptis SA (2011) Insulin effects in muscle and adipose tissue. Diabetes Res Clin Pract 93:S52\u2013S59. https:\/\/doi.org\/10.1016\/S0168-8227(11)70014-6","journal-title":"Diabetes Res Clin Pract"},{"issue":"42","key":"1704_CR33","doi-asserted-by":"publisher","first-page":"32475","DOI":"10.1074\/jbc.M005342200","volume":"275","author":"VW Ding","year":"2000","unstructured":"Ding VW, Chen RH, McCormick F (2000) Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signalling. J Biol Chem 275(42):32475\u201332481. https:\/\/doi.org\/10.1074\/jbc.M005342200","journal-title":"J Biol Chem"},{"key":"1704_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/384017","volume":"2012","author":"AI Duarte","year":"2012","unstructured":"Duarte AI, Moreira PI (2012) Insulin in central nervous system: more than just a peripheral hormone. J Aging Res 2012:384017. https:\/\/doi.org\/10.1155\/2012\/384017","journal-title":"J Aging Res"},{"issue":"7","key":"1704_CR35","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/npp.2010.32","volume":"35","author":"L Escribano","year":"2010","unstructured":"Escribano L, Sim\u00f3n AM, Gimeno E, Cuadrado-Tejedor M, L\u00f3pez de Maturana R, Garc\u00eda-Osta A, Ricobaraza A, P\u00e9rez-Mediavilla A, Del R\u00edo J, Frechilla D (2010) Rosiglitazone rescues memory impairment in Alzheimer\u2019s transgenic mice: mechanisms involving a reduced amyloid and tau pathology. Neuropsychopharmacology 35(7):1593. https:\/\/doi.org\/10.1038\/npp.2010.32","journal-title":"Neuropsychopharmacology"},{"key":"1704_CR36","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/hipo.23002","volume":"10","author":"M Eslami","year":"2018","unstructured":"Eslami M, Sadeghi B, Goshadrou F (2018) Chronic ghrelin administration restores hippocampal long-term potentiation and ameliorates memory impairment in rat model of Alzheimer\u2019s disease. Hippocampus 10:724\u2013734. https:\/\/doi.org\/10.1002\/hipo.23002","journal-title":"Hippocampus"},{"key":"1704_CR37","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.brainresbull.2018.01.001","volume":"137","author":"MH Esmaeili","year":"2018","unstructured":"Esmaeili MH, Bahari B, Salari AA (2018) ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer\u2019s disease. Brain Res Bull 137:265\u2013276. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.01.001","journal-title":"Brain Res Bull"},{"issue":"1","key":"1704_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.trci.2016.11.002","volume":"3","author":"CM Fernandez-Martos","year":"2016","unstructured":"Fernandez-Martos CM, Atkinson RAK, Chuah MI, King AE, Vickers JC (2016) Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer\u2019s disease. Alzheimers Dement (n Y) 3(1):92\u2013106. https:\/\/doi.org\/10.1016\/j.trci.2016.11.002","journal-title":"Alzheimers Dement (n Y)"},{"issue":"1 Suppl","key":"1704_CR39","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/j.jalz.2013.12.010","volume":"10","author":"ST Ferreira","year":"2014","unstructured":"Ferreira ST, Clarke JR, Bomfim TR, De Felice FG (2014) Inflammation, defective insulin signalling, and neuronal dysfunction in Alzheimer\u2019s disease. Alzheimers Dement 10(1 Suppl):S76-83. https:\/\/doi.org\/10.1016\/j.jalz.2013.12.010","journal-title":"Alzheimers Dement"},{"issue":"7","key":"1704_CR40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40263-013-0076-8","volume":"27","author":"J Freiherr","year":"2013","unstructured":"Freiherr J, Hallschmid M, Frey WH 2nd, Br\u00fcnner YF, Chapman CD, H\u00f6lscher C, Craft S, De Felice FG, Benedict C (2013) Intranasal insulin as a treatment for Alzheimer\u2019s disease: a review of basic research and clinical evidence. CNS Drugs 27(7):505\u2013514. https:\/\/doi.org\/10.1007\/s40263-013-0076-8","journal-title":"CNS Drugs"},{"issue":"4\u20135","key":"1704_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s007020050068","volume":"105","author":"L Fr\u00f6lich","year":"1998","unstructured":"Fr\u00f6lich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalheimer A, T\u00fcrk A, Hoyer S, Z\u00f6chling R, Boissl KW, Jellinger K, Riederer P (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer\u2019s disease. J Neural Transm (Vienna) 105(4\u20135):423\u2013438. https:\/\/doi.org\/10.1007\/s007020050068","journal-title":"J Neural Transm (Vienna)"},{"key":"1704_CR42","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2018.11.008","volume":"75","author":"S Gabbouj","year":"2019","unstructured":"Gabbouj S, Natunen T, Koivisto H, Jokivarsi K, Takalo M, Marttinen M, Wittrahm R, Kemppainen S, Naderi R, Posado-Fern\u00e1ndez A, Ryh\u00e4nen S, M\u00e4kinen P, Paldanius KMA, Doria G, Poutiainen P, Flores O, Haapasalo A, Tanila H, Hiltunen M (2019a) Intranasal insulin activates Akt2 signalling pathway in the hippocampus of wild-type but not in APP\/PS1 Alzheimer model mice. Neurobiol Aging 75:98\u2013108. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.11.008","journal-title":"Neurobiol Aging"},{"issue":"13","key":"1704_CR43","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3389\/fnins.2019.00629","volume":"18","author":"S Gabbouj","year":"2019","unstructured":"Gabbouj S, Ryh\u00e4nen S, Marttinen M, Wittrahm R, Takalo M, Kemppainen S, Martiskainen H, Tanila H, Haapasalo A, Hiltunen M, Natunen T (2019b) Altered insulin signalling in Alzheimer\u2019s disease brain - special emphasis on PI3K\u2013Akt pathway. Front Neurosci 18(13):629. https:\/\/doi.org\/10.3389\/fnins.2019.00629","journal-title":"Front Neurosci"},{"key":"1704_CR44","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbadis.2013.11.009","volume":"2","author":"X Gan","year":"2014","unstructured":"Gan X, Huang S, Wu L, Wang Y, Hu G, Li G, Zhang H, Yu H, Swerdlow RH, Chen JX (2014) Inhibition of ERK-DLP1 signalling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer\u2019s disease cybrid cell. Biochim Biophys Acta 2:220\u2013231. https:\/\/doi.org\/10.1016\/j.bbadis.2013.11.009","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"1704_CR45","doi-asserted-by":"publisher","first-page":"346","DOI":"10.7326\/0003-4819-152-6-201003160-00004","volume":"152","author":"AB Goldfine","year":"2010","unstructured":"Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE (2010) TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med 152(6):346\u2013357. https:\/\/doi.org\/10.7326\/0003-4819-152-6-201003160-00004","journal-title":"Ann Intern Med"},{"issue":"1","key":"1704_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-159-1-201307020-00003","volume":"159","author":"AB Goldfine","year":"2013","unstructured":"Goldfine AB, Fonseca V, Jablonski KA, Chen YD, Tipton L, Staten MA, Shoelson SE (2013) Targeting Inflammation Using Salsalate in Type 2 Diabetes Study Team. Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Ann Intern Med 159(1):1\u201312. https:\/\/doi.org\/10.7326\/0003-4819-159-1-201307020-00003","journal-title":"Ann Intern Med"},{"issue":"12","key":"1704_CR47","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/j.1532-5415.1993.tb06480.x","volume":"41","author":"TJ Gradman","year":"1993","unstructured":"Gradman TJ, Laws A, Thompson LW, Reaven GM (1993) Verbal learning and\/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc 41(12):1305\u20131312. https:\/\/doi.org\/10.1111\/j.1532-5415.1993.tb06480.x","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"1704_CR48","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuropharm.2011.01.033","volume":"60","author":"A Gupta","year":"2011","unstructured":"Gupta A, Bisht B, Dey CS (2011) Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer\u2019s-like changes. Neuropharmacology 60(6):910\u2013920. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.01.033","journal-title":"Neuropharmacology"},{"issue":"5","key":"1704_CR49","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nsmb.1418","volume":"15","author":"J Gureasko","year":"2008","unstructured":"Gureasko J, Galush WJ, Boykevisch S, Sondermann H, Bar-Sagi D, Groves JT, Kuriyan J (2008) Membrane-dependent signal integration by the Ras activator Son of sevenless. Nat Struct Mol Iol 15(5):452\u2013461. https:\/\/doi.org\/10.1038\/nsmb.1418","journal-title":"Nat Struct Mol Iol"},{"issue":"10","key":"1704_CR50","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A (2021) The Amyloid-\u03b2 Pathway in Alzheimer\u2019s Disease. Mol Psychiatry 26(10):5481\u20135503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0","journal-title":"Mol Psychiatry"},{"issue":"2","key":"1704_CR51","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/1531-8249(20010201)49:2<276::AID-ANA53>3.0.CO;2-5","volume":"49","author":"MT Heneka","year":"2001","unstructured":"Heneka MT, Landreth GE, Feinstein DL (2001) Role for peroxisome proliferator-activated receptor-gamma in Alzheimer\u2019s disease. Ann Neurol 49(2):276","journal-title":"Ann Neurol"},{"issue":"2","key":"1704_CR52","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.expneurol.2009.09.011","volume":"223","author":"F Hern\u00e1ndez","year":"2010","unstructured":"Hern\u00e1ndez F, G\u00f3mez de Barreda E, Fuster-Matanzo A, Lucas JJ, Avila J (2010) GSK3: a possible link between beta amyloid peptide and tau protein. Exp Neurol 223(2):322\u2013325. https:\/\/doi.org\/10.1016\/j.expneurol.2009.09.011","journal-title":"Exp Neurol"},{"issue":"1","key":"1704_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1755-5949.2010.00221.x","volume":"18","author":"HS Hoe","year":"2012","unstructured":"Hoe HS, Lee HK, Pak DT (2012) The upside of APP at synapses. CNS Neurosci Ther 18(1):47\u201356. https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00221.x","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"1704_CR54","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3233\/JAD-2011-101524","volume":"24","author":"CC Hsu","year":"2011","unstructured":"Hsu CC, Wahlqvist ML, Lee MS, Tsai HN (2011) Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J Alzheimers Dis 24(3):485\u2013493. https:\/\/doi.org\/10.3233\/JAD-2011-101524","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1704_CR55","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3109\/10799893.2013.848891","volume":"34","author":"HC Huang","year":"2014","unstructured":"Huang HC, Tang D, Xu K, Jiang ZF (2014) Curcumin attenuates amyloid-\u03b2-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN\/Akt\/GSK-3\u03b2 signalling pathway. J Recept Signal Transduct Res 34(1):26\u201337. https:\/\/doi.org\/10.3109\/10799893.2013.848891","journal-title":"J Recept Signal Transduct Res"},{"key":"1704_CR56","doi-asserted-by":"publisher","first-page":"1117683","DOI":"10.3389\/fphar.2023.1117683","volume":"14","author":"M H\u00fcttl","year":"2023","unstructured":"H\u00fcttl M, Markova I, Mikl\u00e1nkov\u00e1 D, Zapletalova I, Kujal P, \u0160ilhav\u00fd J, Pravenec M, Malinska H (2023) Hypolipidemic and insulin sensitizing effects of salsalate beyond suppressing inflammation in a prediabetic rat model. Front Pharmacol 14:1117683. https:\/\/doi.org\/10.3389\/fphar.2023.1117683","journal-title":"Front Pharmacol"},{"issue":"247","key":"1704_CR57","doi-asserted-by":"publisher","first-page":"pe47","DOI":"10.1126\/scisignal.2003511","volume":"5","author":"R Kang","year":"2012","unstructured":"Kang R, Tang D (2012) PKR-dependent inflammatory signals. Sci Signal 5(247):pe47. https:\/\/doi.org\/10.1126\/scisignal.2003511","journal-title":"Sci Signal"},{"issue":"50","key":"1704_CR58","doi-asserted-by":"publisher","first-page":"21830","DOI":"10.1073\/pnas.0912793107","volume":"107","author":"E Kickstein","year":"2010","unstructured":"Kickstein E, Krauss S, Thornhill P, Rutschow D, Zeller R, Sharkey J, Williamson R, Fuchs M, K\u00f6hler A, Glossmann H, Schneider R, Sutherland C, Schweiger S (2010) Biguanide metformin acts on tau phosphorylation via mTOR\/protein phosphatase 2A (PP2A) signalling. Proc Natl Acad Sci USA 107(50):21830\u201321835. https:\/\/doi.org\/10.1073\/pnas.0912793107","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1704_CR59","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.2337\/db14-0568","volume":"63","author":"A Kleinridders","year":"2014","unstructured":"Kleinridders A, Ferris HA, Cai W, Kahn CR (2014) Insulin action in brain regulates systemic metabolism and brain function. Diabetes 63(7):2232\u20132243. https:\/\/doi.org\/10.2337\/db14-0568","journal-title":"Diabetes"},{"issue":"7","key":"1704_CR60","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/cns.12404","volume":"21","author":"E Kornelius","year":"2015","unstructured":"Kornelius E, Lin CL, Chang HH, Li HH, Huang WN, Yang YS, Lu YL, Peng CH, Huang CN (2015) DPP-4 Inhibitor linagliptin attenuates A\u03b2-induced cytotoxicity through activation of AMPK in neuronal cells. CNS Neurosci Ther 21(7):549\u2013557. https:\/\/doi.org\/10.1111\/cns.12404","journal-title":"CNS Neurosci Ther"},{"key":"1704_CR61","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neulet.2016.12.065","volume":"639","author":"MS Kruse","year":"2017","unstructured":"Kruse MS, Suarez LG, Coirini H (2017) Regulation of the expression of LXR in rat hypothalamic and hippocampal explants. Neurosci Lett 639:53\u201358. https:\/\/doi.org\/10.1016\/j.neulet.2016.12.065","journal-title":"Neurosci Lett"},{"issue":"17","key":"1704_CR62","doi-asserted-by":"publisher","first-page":"9540","DOI":"10.3390\/ijms23179540","volume":"23","author":"V Kumar","year":"2022","unstructured":"Kumar V, Kim SH, Bishayee K (2022) Dysfunctional glucose metabolism in Alzheimer\u2019s disease onset and potential pharmacological interventions. Int J Mol Sci 23(17):9540. https:\/\/doi.org\/10.3390\/ijms23179540","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1704_CR63","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/(SICI)1097-4547(19970901)49:5<617::AID-JNR12>3.0.CO;2-S","volume":"49","author":"RL Leino","year":"1997","unstructured":"Leino RL, Gerhart DZ, van Bueren AM, McCall AL, Drewes LR (1997) Ultrastructural localization of GLUT 1 and GLUT 3 glucose transporters in rat brain. J Neurosci Res 49(5):617\u2013626","journal-title":"J Neurosci Res"},{"issue":"7","key":"1704_CR64","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","volume":"141","author":"MA Lemmon","year":"2010","unstructured":"Lemmon MA, Schlessinger J (2010) Cell signalling by receptor tyrosine kinases. Cell 141(7):1117\u20131134. https:\/\/doi.org\/10.1016\/j.cell.2010.06.011","journal-title":"Cell"},{"issue":"4","key":"1704_CR65","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.pbb.2012.03.002","volume":"101","author":"J Li","year":"2012","unstructured":"Li J, Deng J, Sheng W, Zuo Z (2012) Metformin attenuates Alzheimer\u2019s disease-like neuropathology in obese, leptin-resistant mice. Pharmacol Biochem Behav 101(4):564\u2013574. https:\/\/doi.org\/10.1016\/j.pbb.2012.03.002","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"1704_CR66","doi-asserted-by":"publisher","first-page":"e01505","DOI":"10.1002\/brb3.1505","volume":"10","author":"C Li","year":"2020","unstructured":"Li C, Liu W, Li X, Zhang Z, Qi H, Liu S, Yan N, Xing Y, H\u00f6lscher C, Wang Z (2020) The novel GLP-1\/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the ICV. STZ rat model of AD. Brain Behav 10(3):e01505. https:\/\/doi.org\/10.1002\/brb3.1505","journal-title":"Brain Behav"},{"issue":"1","key":"1704_CR67","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/path.2912","volume":"225","author":"Y Liu","year":"2011","unstructured":"Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2011) Deficient brain insulin signalling pathway in Alzheimer\u2019s disease and diabetes. J Pathol 225(1):54\u201362. https:\/\/doi.org\/10.1002\/path.2912","journal-title":"J Pathol"},{"key":"1704_CR68","doi-asserted-by":"publisher","first-page":"2525967","DOI":"10.1155\/2017\/2525967","volume":"2017","author":"Z Liu","year":"2017","unstructured":"Liu Z, Zhou T, Ziegler AC, Dimitrion P (2017) Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Oxid Med Cell Longev 2017:2525967. https:\/\/doi.org\/10.1155\/2017\/2525967","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"1704_CR69","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/s41598-019-39191-5","volume":"9","author":"JJ Lochhead","year":"2019","unstructured":"Lochhead JJ, Kellohen KL, Ronaldson PT, Davis TP (2019) Distribution of insulin in trigeminal nerve and brain after intranasal administration. Sci Rep 9(1):2621. https:\/\/doi.org\/10.1038\/s41598-019-39191-5","journal-title":"Sci Rep"},{"issue":"6","key":"1704_CR70","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","volume":"18","author":"MV Lourenco","year":"2013","unstructured":"Lourenco MV, Clarke JR, Frozza RL, Bomfim TR, Forny-Germano L, Batista AF, Sathler LB, Brito-Moreira J, Amaral OB, Silva CA, Freitas-Correa L, Esp\u00edrito-Santo S, Campello-Costa P, Houzel JC, Klein WL, Holscher C, Carvalheira JB, Silva AM, Velloso LA, Munoz DP, Ferreira ST, De Felice FG (2013) TNF-\u03b1 mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer\u2019s \u03b2-amyloid oligomers in mice and monkeys. Cell Metab 18(6):831\u2013843","journal-title":"Cell Metab"},{"issue":"9","key":"1704_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012845","volume":"5","author":"T Ma","year":"2010","unstructured":"Ma T, Hoeffer CA, Capetillo-Zarate E, Yu F, Wong H, Lin MT, Tampellini D, Klann E, Blitzer RD, Gouras GK (2010) Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer\u2019s disease. PLoS ONE 5(9):e12845. https:\/\/doi.org\/10.1371\/journal.pone.0012845","journal-title":"PLoS ONE"},{"key":"1704_CR72","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuropharm.2013.08.005","volume":"76","author":"PL McClean","year":"2014","unstructured":"McClean PL, H\u00f6lscher C (2014) Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer\u2019s disease. Neuropharmacology 76:57\u201367. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.08.005","journal-title":"Neuropharmacology"},{"issue":"10","key":"1704_CR73","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","volume":"36","author":"P Mergenthaler","year":"2013","unstructured":"Mergenthaler P, Lindauer U, Dienel GA, Meisel A (2013) Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci 36(10):587\u2013597. https:\/\/doi.org\/10.1016\/j.tins.2013.07.001","journal-title":"Trends Neurosci"},{"issue":"3","key":"1704_CR74","first-page":"617","volume":"35","author":"HJ Min","year":"2009","unstructured":"Min HJ, Koh SS, Cho IR, Srisuttee R, Park EH, Jhun BH, Kim YG, Oh S, Kwak JE, Johnston RN, Chung YH (2009) Inhibition of GSK-3beta enhances reovirus-induced apoptosis in colon cancer cells. Int J Oncol 35(3):617\u2013624","journal-title":"Int J Oncol"},{"key":"1704_CR75","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/nm.3951","volume":"10","author":"SW Min","year":"2015","unstructured":"Min SW, Chen X, Tracy TE, Li Y, Zhou Y, Wang C, Shirakawa K, Minami SS, Defensor E, Mok SA, Sohn PD, Schilling B, Cong X, Ellerby L, Gibson BW, Johnson J, Krogan N, Shamloo M, Gestwicki J, Masliah E, Verdin E, Gan L (2015) Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. Nat Med 10:1154\u20131162. https:\/\/doi.org\/10.1038\/nm.3951","journal-title":"Nat Med"},{"issue":"2","key":"1704_CR76","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","volume":"31","author":"AM Moloney","year":"2010","unstructured":"Moloney AM, Griffin RJ, Timmons S, O\u2019Connor R, Ravid R, O\u2019Neill C (2010) Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 31(2):224\u2013243. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.04.002","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1704_CR77","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.neuropharm.2009.11.010","volume":"58","author":"L Munoz","year":"2010","unstructured":"Munoz L, Ammit AJ (2010) Targeting p38 MAPK pathway for the treatment of Alzheimer\u2019s disease. Neuropharmacology 58(3):561\u2013568. https:\/\/doi.org\/10.1016\/j.neuropharm.2009.11.010","journal-title":"Neuropharmacology"},{"issue":"2","key":"1704_CR78","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1600-079X.2010.00821.x","volume":"50","author":"G Negi","year":"2011","unstructured":"Negi G, Kumar A, Sharma SS (2011) Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-\u03baB and Nrf2 cascades. J Pineal Res 50(2):124\u2013131. https:\/\/doi.org\/10.1111\/j.1600-079X.2010.00821.x","journal-title":"J Pineal Res"},{"key":"1704_CR79","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neuropharm.2015.09.030","volume":"101","author":"C Osborne","year":"2016","unstructured":"Osborne C, West E, Nolan W, McHale-Owen H, Williams A, Bate C (2016) Glimepiride protects neurons against amyloid-\u03b2-induced synapse damage. Neuropharmacology 101:225\u2013236. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.09.030","journal-title":"Neuropharmacology"},{"issue":"1","key":"1704_CR80","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3233\/JAD-180584","volume":"66","author":"T Panagaki","year":"2018","unstructured":"Panagaki T, Gengler S, H\u00f6lscher C (2018) The Novel DA-CH3 dual incretin restores endoplasmic reticulum stress and autophagy impairments to attenuate Alzheimer-like pathology and cognitive decrements in the APPSWE\/PS1\u0394E9 Mouse Model. J Alzheimers Dis 66(1):195\u2013218. https:\/\/doi.org\/10.3233\/JAD-180584","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1704_CR81","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1210\/en.2012-1661","volume":"154","author":"G Pandini","year":"2013","unstructured":"Pandini G, Pace V, Copani A, Squatrito S, Milardi D, Vigneri R (2013) Insulin has multiple antiamyloidogenic effects on human neuronal cells. Endocrinology 154(1):375\u2013387. https:\/\/doi.org\/10.1210\/en.2012-1661","journal-title":"Endocrinology"},{"issue":"23","key":"1704_CR82","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.lfs.2006.07.018","volume":"79","author":"AR Pathan","year":"2006","unstructured":"Pathan AR, Viswanad B, Sonkusare SK, Ramarao P (2006) Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats. Life Sci 79(23):2209\u20132216. https:\/\/doi.org\/10.1016\/j.lfs.2006.07.018","journal-title":"Life Sci"},{"issue":"3","key":"1704_CR83","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1124\/jpet.102.037481","volume":"302","author":"T Perry","year":"2002","unstructured":"Perry T, Haughey NJ, Mattson MP, Egan JM, Greig NH (2002) Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4. J Pharmacol Exp Ther 302(3):881\u2013888. https:\/\/doi.org\/10.1124\/jpet.102.037481","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1704_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/JOE-12-0521","volume":"218","author":"H Pintana","year":"2013","unstructured":"Pintana H, Apaijai N, Chattipakorn N, Chattipakorn SC (2013) DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats. J Endocrinol 218(1):1\u201311. https:\/\/doi.org\/10.1530\/JOE-12-0521","journal-title":"J Endocrinol"},{"issue":"5","key":"1704_CR85","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/ejn.12088","volume":"37","author":"N Pipatpiboon","year":"2013","unstructured":"Pipatpiboon N, Pintana H, Pratchayasakul W, Chattipakorn N, Chattipakorn SC (2013) DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption. Eur J Neurosci 37(5):839\u2013849. https:\/\/doi.org\/10.1111\/ejn.12088","journal-title":"Eur J Neurosci"},{"issue":"5","key":"1704_CR86","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1750-1326-5-7","volume":"26","author":"CJ Proctor","year":"2010","unstructured":"Proctor CJ, Gray DA (2010) GSK3 and p53 - is there a link in Alzheimer\u2019s disease? Mol Neurodegener 26(5):7","journal-title":"Mol Neurodegener"},{"issue":"2","key":"1704_CR87","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.nbd.2008.10.007","volume":"33","author":"CJ Proctor","year":"2009","unstructured":"Proctor CJ, Begum AN, Jones MR, Oh MS, Beech WK, Beech BH, Yang F, Chen P, Ubeda OJ, Kim PC, Davies P, Ma Q, Cole GM, Frautschy SA (2009) GSK3 inhibitors show benefits in an Alzheimer\u2019s disease (AD) model of neurodegeneration but adverse effects in control animals. Neurobiol Dis 33(2):193\u2013206. https:\/\/doi.org\/10.1016\/j.nbd.2008.10.007","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1704_CR88","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11064-009-0047-0","volume":"35","author":"M Racaniello","year":"2010","unstructured":"Racaniello M, Cardinale A, Mollinari C, D\u2019Antuono M, De Chiara G, Tancredi V, Merlo D (2010) Phosphorylation changes of CaMKII, ERK1\/2, PKB\/Akt kinases and CREB activation during early long-term potentiation at Schaffer collateral-CA1 mouse hippocampal synapses. Neurochem Res 35(2):239\u2013246. https:\/\/doi.org\/10.1007\/s11064-009-0047-0","journal-title":"Neurochem Res"},{"key":"1704_CR89","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.2147\/DDDT.S173970","volume":"12","author":"SK Rad","year":"2018","unstructured":"Rad SK, Arya A, Karimian H, Madhavan P, Rizwan F, Koshy S, Prabhu G (2018) Mechanism involved in insulin resistance via accumulation of \u03b2-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer\u2019s disease. Drug des Devel Ther 12:3999\u20134021. https:\/\/doi.org\/10.2147\/DDDT.S173970","journal-title":"Drug des Devel Ther"},{"issue":"3","key":"1704_CR90","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","volume":"27","author":"MA Reger","year":"2006","unstructured":"Reger MA, Watson GS, Frey WH 2nd, Baker LD, Cholerton B, Keeling ML, Belongia DA, Fishel MA, Plymate SR, Schellenberg GD, Cherrier MM, Craft S (2006) Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging 27(3):451\u2013458. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.03.016","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1704_CR91","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/jad-2008-13309","volume":"13","author":"MA Reger","year":"2008","unstructured":"Reger MA, Watson GS, Green PS, Baker LD, Cholerton B, Fishel MA, Plymate SR, Cherrier MM, Schellenberg GD, Frey WH 2nd, Craft S (2008) Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis 13(3):323\u2013331. https:\/\/doi.org\/10.3233\/jad-2008-13309","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"1704_CR92","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/gerona\/glu032","volume":"69","author":"MR Rizzo","year":"2014","unstructured":"Rizzo MR, Barbieri M, Boccardi V, Angellotti E, Marfella R, Paolisso G (2014) Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment. J Gerontol A Biol Sci Med Sci 69(9):1122\u20131131. https:\/\/doi.org\/10.1093\/gerona\/glu032","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"9","key":"1704_CR93","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.neurobiolaging.2009.10.009","volume":"32","author":"T Sato","year":"2011","unstructured":"Sato T, Hanyu H, Hirao K, Kanetaka H, Sakurai H, Iwamoto T (2011) Efficacy of PPAR-\u03b3 agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging 32(9):1626\u20131633. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.10.009","journal-title":"Neurobiol Aging"},{"issue":"18","key":"1704_CR94","doi-asserted-by":"publisher","first-page":"9987","DOI":"10.3390\/ijms22189987","volume":"22","author":"A S\u0119dzikowska","year":"2013","unstructured":"S\u0119dzikowska A, Szablewski L (2013) Insulin and insulin resistance in Alzheimer\u2019s disease. Int J Mol Sci 22(18):9987. https:\/\/doi.org\/10.3390\/ijms22189987","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1704_CR95","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.nbd.2009.05.025","volume":"35","author":"L Seren\u00f3","year":"2009","unstructured":"Seren\u00f3 L, Coma M, Rodr\u00edguez M, S\u00e1nchez-Ferrer P, S\u00e1nchez MB, Gich I, Agull\u00f3 JM, P\u00e9rez M, Avila J, Guardia-Laguarta C, Clarim\u00f3n J, Lle\u00f3 A, G\u00f3mez-Isla T (2009) A novel GSK-3beta inhibitor reduces Alzheimer\u2019s pathology and rescues neuronal loss in vivo. Neurobiol Dis 35(3):359\u2013367. https:\/\/doi.org\/10.1016\/j.nbd.2009.05.025","journal-title":"Neurobiol Dis"},{"issue":"7575","key":"1704_CR96","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F (2015) Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526(7575):660\u2013665. https:\/\/doi.org\/10.1038\/nature15514","journal-title":"Nature"},{"key":"1704_CR97","doi-asserted-by":"publisher","first-page":"4981814","DOI":"10.1155\/2020\/4981814","volume":"2020","author":"Y Sun","year":"2020","unstructured":"Sun Y, Ma C, Sun H, Wang H, Peng W, Zhou Z, Wang H, Pi C, Shi Y, He X (2020) Metabolism: a novel shared link between diabetes mellitus and Alzheimer\u2019s disease. J Diabetes Res 2020:4981814. https:\/\/doi.org\/10.1155\/2020\/4981814","journal-title":"J Diabetes Res"},{"issue":"2","key":"1704_CR98","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cbpb.2006.02.006","volume":"144","author":"H Takle","year":"2006","unstructured":"Takle H, McLeod A, Andersen O (2006) Cloning and characterization of the executioner caspases 3, 6, 7 and Hsp70 in hyperthermic Atlantic salmon (Salmo salar) embryos. Comp Biochem Physiol B Biochem Mol Biol 144(2):188\u2013198. https:\/\/doi.org\/10.1016\/j.cbpb.2006.02.006","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"issue":"1","key":"1704_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10495-007-0154-9","volume":"13","author":"A Thorburn","year":"2008","unstructured":"Thorburn A (2008) Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis 13(1):1\u20139. https:\/\/doi.org\/10.1007\/s10495-007-0154-9","journal-title":"Apoptosis"},{"issue":"4","key":"1704_CR100","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.pneurobio.2006.06.003","volume":"79","author":"LP Van der Heide","year":"2006","unstructured":"Van der Heide LP, Ramakers GM, Smidt MP (2006) Insulin signalling in the central nervous system: learning to survive. Prog Neurobiol 79(4):205\u2013221. https:\/\/doi.org\/10.1016\/j.pneurobio.2006.06.003","journal-title":"Prog Neurobiol"},{"issue":"2","key":"1704_CR101","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1677\/JOE-08-0061","volume":"197","author":"R Vinayagamoorthi","year":"2008","unstructured":"Vinayagamoorthi R, Bobby Z, Sridhar MG (2008) Antioxidants preserve redox balance and inhibit c-Jun-N-terminal kinase pathway while improving insulin signalling in fat-fed rats: evidence for the role of oxidative stress on IRS-1 serine phosphorylation and insulin resistance. J Endocrinol 197(2):287\u2013296. https:\/\/doi.org\/10.1677\/JOE-08-0061","journal-title":"J Endocrinol"},{"issue":"2","key":"1704_CR102","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1254\/jphs.crj05006x","volume":"99","author":"A Wada","year":"2005","unstructured":"Wada A, Yokoo H, Yanagita T, Kobayashi H (2005) New twist on neuronal insulin receptor signalling in health, disease, and therapeutics. J Pharmacol Sci 99(2):128\u2013143. https:\/\/doi.org\/10.1254\/jphs.crj05006x","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"1704_CR103","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13041-019-0432-9","volume":"12","author":"L Wang","year":"2019","unstructured":"Wang L, Zhang R, Hou X, Wang C, Guo S, Ning N, Sun C, Yuan Y, Li L, H\u00f6lscher C, Wang X (2019) DA-JC1 improves learning and memory by antagonizing A\u03b231-35-induced circadian rhythm disorder. Mol Brain 12(1):14. https:\/\/doi.org\/10.1186\/s13041-019-0432-9","journal-title":"Mol Brain"},{"issue":"11","key":"1704_CR104","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1176\/appi.ajgp.13.11.950","volume":"13","author":"GS Watson","year":"2005","unstructured":"Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, Fishel MA, Kulstad JJ, Green PS, Cook DG, Kahn SE, Keeling ML, Craft S (2005) Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry 13(11):950\u2013958. https:\/\/doi.org\/10.1176\/appi.ajgp.13.11.950","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"1704_CR105","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/JIM.0000000000000129","volume":"63","author":"W Xu","year":"2015","unstructured":"Xu W, Yang Y, Yuan G, Zhu W, Ma D, Hu S (2015) Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes. J Investig Med 63(2):267\u2013272. https:\/\/doi.org\/10.1097\/JIM.0000000000000129","journal-title":"J Investig Med"},{"issue":"5","key":"1704_CR106","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00401-014-1328-5","volume":"128","author":"M Yarchoan","year":"2014","unstructured":"Yarchoan M, Toledo JB, Lee EB, Arvanitakis Z, Kazi H, Han LY, Louneva N, Lee VM, Kim SF, Trojanowski JQ, Arnold SE (2014) Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer\u2019s disease and tauopathies. Acta Neuropathol 128(5):679\u2013689. https:\/\/doi.org\/10.1007\/s00401-014-1328-5","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1704_CR107","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00702-014-1294-z","volume":"122","author":"Y Yu","year":"2015","unstructured":"Yu Y, Li X, Blanchard J, Li Y, Iqbal K, Liu F, Gong CX (2015) Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice. J Neural Transm (Vienna) 122(4):593\u2013606. https:\/\/doi.org\/10.1007\/s00702-014-1294-z","journal-title":"J Neural Transm (Vienna)"},{"issue":"1\u20133","key":"1704_CR108","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejphar.2004.02.045","volume":"490","author":"WQ Zhao","year":"2004","unstructured":"Zhao WQ, Chen H, Quon MJ, Alkon DL (2004) Insulin and the insulin receptor in experimental models of learning and memory. Eur J Pharmacol 490(1\u20133):71\u201381. https:\/\/doi.org\/10.1016\/j.ejphar.2004.02.045","journal-title":"Eur J Pharmacol"},{"issue":"28","key":"1704_CR109","doi-asserted-by":"publisher","first-page":"18742","DOI":"10.1074\/jbc.M109.011015","volume":"284","author":"WQ Zhao","year":"2009","unstructured":"Zhao WQ, Lacor PN, Chen H, Lambert MP, Quon MJ, Krafft GA, Klein WL (2009) Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}. J Biol Chem 284(28):18742\u201318753. https:\/\/doi.org\/10.1074\/jbc.M109.011015","journal-title":"J Biol Chem"},{"issue":"1","key":"1704_CR110","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12035-013-8595-3","volume":"50","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Bhattacharjee S, Jones BM, Hill J, Dua P, Lukiw WJ (2014) Regulation of neurotropic signalling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer\u2019s disease (AD) and in primary human neuronal-glial (HNG) cells. Mol Neurobiol 50(1):97\u2013106. https:\/\/doi.org\/10.1007\/s12035-013-8595-3","journal-title":"Mol Neurobiol"},{"issue":"3","key":"1704_CR111","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.pnpbp.2010.04.011","volume":"35","author":"PA Zunszain","year":"2011","unstructured":"Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM (2011) Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry 35(3):722\u2013729. https:\/\/doi.org\/10.1016\/j.pnpbp.2010.04.011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01704-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01704-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01704-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T20:02:10Z","timestamp":1744401730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01704-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1704"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01704-2","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial and non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}